|
Volumn 77, Issue 913, 2001, Pages 694-699
|
Management of neurogenic dysphagia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLCHOLINE;
BENZODIAZEPINE DERIVATIVE;
BOTULINUM TOXIN A;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
HYPNOTIC AGENT;
NEUROLEPTIC AGENT;
SEDATIVE AGENT;
BASAL GANGLION;
BRAIN CORTEX;
CLINICAL EXAMINATION;
CLINICAL FEATURE;
CRICOPHARYNGEUS MUSCLE;
DIET THERAPY;
DIFFERENTIAL DIAGNOSIS;
DYSPHAGIA;
ENTERIC FEEDING;
ESOPHAGUS MYOTOMY;
HUMAN;
NEUROPATHOLOGY;
PATHOPHYSIOLOGY;
REVIEW;
DEGLUTITION DISORDERS;
DIAGNOSIS, DIFFERENTIAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENTERAL NUTRITION;
HUMANS;
NERVOUS SYSTEM DISEASES;
PHYSICAL THERAPY MODALITIES;
POINT-OF-CARE SYSTEMS;
|
EID: 0034751255
PISSN: 00325473
EISSN: None
Source Type: Journal
DOI: 10.1136/pmj.77.913.694 Document Type: Review |
Times cited : (57)
|
References (20)
|